| Literature DB >> 29675737 |
Jennifer R Heimall1, David Hagin2, Joud Hajjar3, Sarah E Henrickson4,5, Hillary S Hernandez-Trujillo6,7, Yuval Tan8, Lisa Kobrynski9, Kenneth Paris10, Troy R Torgerson11, James W Verbsky12, Richard L Wasserman13, Elena W Y Hsieh14, Jack J Blessing15, Janet S Chou16,17, Monica G Lawrence18, Rebecca A Marsh19, Sergio D Rosenzweig20, Jordan S Orange21,22, Roshini S Abraham23.
Abstract
Genetic testing plays a critical role in diagnosis for many primary immunodeficiency diseases. The goals of this report are to outline some of the challenges that clinical immunologists face routinely in the use of genetic testing for patient care. In addition, we provide a review of the types of genetic testing used in the diagnosis of PID, including their strengths and limitations. We describe the strengths and limitations of different genetic testing approaches for specific clinical contexts that raise concern for specific PID disorders in light of the challenges reported by the clinical immunologist members of the CIS in a recent membership survey. Finally, we delineate the CIS's recommendations for the use of genetic testing in light of these issues.Entities:
Keywords: Immunodeficiency; genetic testing; sanger sequencing; whole exome testing; whole genome testing
Mesh:
Substances:
Year: 2018 PMID: 29675737 DOI: 10.1007/s10875-018-0489-8
Source DB: PubMed Journal: J Clin Immunol ISSN: 0271-9142 Impact factor: 8.317